News

A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...
Omada Health is making its public-market debut, propelled by Americans’ renewed focus on how weight affects physical health.
Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Researchers at the University of Toronto have found GLP-1 weight loss and diabetes drugs like Ozempic and Mounjaro double the ...
A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.
Ozempic teeth” is a term used to describe the unexpected dental side effects of Ozempic, including bad breath, gum irritation ...
Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 ...
Dr. Shervin Naderi and his team integrate facial rejuvenation with weight loss care to manage the structural facial changes ...
US woman Caroline Davis shared incredible before and after images of her weight loss after using semaglutide drug Wegovy.
After reviewing several large epidemiological studies, clinical trial and in-market data, EMA’s Pharmacovigilance Risk Assessment Committee has concluded non-anterior ischemic optic neuropathy is a ...
Demand for cosmetic procedures to fix Sydneysiders’ saggy skin and lost facial fat associated with weight-loss drugs has ...